Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

Université Laval

$27,000.00

Association between hemoglobin concentration and functional recovery in anemic patients with moderate to severe traumatic brain injury admitted to the intensive care unit: A secondary analysis of the international randomized clinical trial HEMOTION.

EF 2025-26

Résumé
Traumatic brain injury (TBI) is a leading cause of death and long-term disability worldwide. Few treatments improve patient outcomes. Up to 60% of patients admitted to the intensive care unit after TBI develop anemia, a condition that can worsen secondary brain injury by reducing oxygen delivery. Anemia on admission is a key driver of poor recovery, yet the influence of hemoglobin concentration (HbC) trajectories on long-term outcomes remains largely unexplored. This study will use data from the HEMOTION trial, a large international randomized controlled trial comparing liberal (?100 g/L) versus restrictive (?70 g/L) transfusion thresholds in 742 anemic moderate-to-severe TBI patients. All HbC measurements collected will be leveraged throughout hospitalization to characterize HbC trajectories. A time-weighted area-under-the-curve method will quantify how maintaining HbC above clinically meaningful thresholds (e.g. ?70 g/L) relates to 6-month functional outcomes and mortality. Functional outcomes will be measured using the Glasgow Outcome Scale-extended at 6 months. Mortality will be assessed in the ICU, during hospitalization and at 6 months. The study will identify actionable HbC thresholds, periods when HbC has the strongest impact on recovery and whether associations differ across subgroups such as sex. Multivariable mixed effects and time-to-event models will account for baseline prognostic factors and hospital-level clustering. By moving beyond single HbC values to capture both the magnitude and duration of anemia, this study aims to generate clinically relevant evidence to inform transfusion practices. The findings could ultimately support interventions that reduce mortality, improve functional recovery and long-term quality of life for TBI patients.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572705
Name
Imrith Kendy
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Association between hemoglobin concentration and functional recovery in anemic patients with moderate to severe traumatic brain injury admitted to the intensive care unit: A secondary analysis of the international randomized clinical trial HEMOTION.
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Anemia; Area Under The Curve; Critical Care; Glasgow Outcome Scale-Extended; Hemoglobin Concentration; Longterm Functional Recovery; Neurotrauma; Quality Of Life; Survival; Traumatic Brain Injury
Abstract
Traumatic brain injury (TBI) is a leading cause of death and long-term disability worldwide. Few treatments improve patient outcomes. Up to 60% of patients admitted to the intensive care unit after TBI develop anemia, a condition that can worsen secondary brain injury by reducing oxygen delivery. Anemia on admission is a key driver of poor recovery, yet the influence of hemoglobin concentration (HbC) trajectories on long-term outcomes remains largely unexplored. This study will use data from the HEMOTION trial, a large international randomized controlled trial comparing liberal (?100 g/L) versus restrictive (?70 g/L) transfusion thresholds in 742 anemic moderate-to-severe TBI patients. All HbC measurements collected will be leveraged throughout hospitalization to characterize HbC trajectories. A time-weighted area-under-the-curve method will quantify how maintaining HbC above clinically meaningful thresholds (e.g. ?70 g/L) relates to 6-month functional outcomes and mortality. Functional outcomes will be measured using the Glasgow Outcome Scale-extended at 6 months. Mortality will be assessed in the ICU, during hospitalization and at 6 months. The study will identify actionable HbC thresholds, periods when HbC has the strongest impact on recovery and whether associations differ across subgroups such as sex. Multivariable mixed effects and time-to-event models will account for baseline prognostic factors and hospital-level clustering. By moving beyond single HbC values to capture both the magnitude and duration of anemia, this study aims to generate clinically relevant evidence to inform transfusion practices. The findings could ultimately support interventions that reduce mortality, improve functional recovery and long-term quality of life for TBI patients.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Imrith, Kendy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~